Compounds > dactinomycin

dactinomycin and Sarcoma, Small Cell

dactinomycin has been researched along with Sarcoma, Small Cell in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Antonescu, CR; Coindre, JM; Italiano, A; Maki, RG; Singer, S; Sung, YS; Zhang, L1
Conrad, EU; Park, JR; Sawin, RS; Waldhausen, JH1
Bisogno, G; Carli, M; di Montezemolo, LC; Donfrancesco, A; Mascarin, M; Ninfo, V; Roganovich, J; Sotti, G1

Other Studies

3 other study(ies) available for dactinomycin and Sarcoma, Small Cell

ArticleYear
High prevalence of CIC fusion with double-homeobox (DUX4) transcription factors in EWSR1-negative undifferentiated small blue round cell sarcomas.
    Genes, chromosomes & cancer, 2012, Volume: 51, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Biomarkers, Tumor; Chromosomes, Human, Pair 10; Chromosomes, Human, Pair 4; Cyclophosphamide; Dactinomycin; Gene Rearrangement; Homeodomain Proteins; Humans; In Situ Hybridization, Fluorescence; Male; Middle Aged; Molecular Sequence Data; Oncogene Fusion; Oncogene Proteins, Fusion; Repressor Proteins; RNA-Binding Protein FUS; Sarcoma, Small Cell; Soft Tissue Neoplasms; Translocation, Genetic; Vincristine

2012
Preresection chemotherapy improves survival for children with Askin tumors.
    Archives of surgery (Chicago, Ill. : 1960), 1996, Volume: 131, Issue:8

    Topics: Adolescent; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Infant; Male; Radiotherapy, Adjuvant; Retrospective Studies; Sarcoma, Small Cell; Survival Analysis; Thoracic Neoplasms; Time Factors; Treatment Outcome; Vincristine

1996
Desmoplastic small round cell tumour in children and adolescents.
    Medical and pediatric oncology, 2000, Volume: 34, Issue:5

    Topics: Abdominal Neoplasms; Adolescent; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Dactinomycin; Disease-Free Survival; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Prognosis; Remission Induction; Salvage Therapy; Sarcoma, Small Cell; Survival Rate; Testicular Neoplasms; Vincristine

2000